Researchers at Humanitas Clinical and Research Hospital Target Liver Cancer (Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: a Proof-of-Concept Trial)

MLA

“Researchers at Humanitas Clinical and Research Hospital Target Liver Cancer (Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Proof-of-Concept Trial).” Obesity, Fitness & Wellness Week, Nov. 2020, p. 1620. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.642493768&authtype=sso&custid=ns315887.

APA

Researchers at Humanitas Clinical and Research Hospital Target Liver Cancer (Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: a Proof-of-Concept Trial). (2020, November 28). Obesity, Fitness & Wellness Week, 1620.

Chicago

Obesity, Fitness & Wellness Week. 2020. “Researchers at Humanitas Clinical and Research Hospital Target Liver Cancer (Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Proof-of-Concept Trial),” November 28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.642493768&authtype=sso&custid=ns315887.